Interestingly, heterozygous mutations in FA genes, i.e., BRCA1/FANCS and BRCA2/FANCD1, confer an increased risk of cancer occurrence, especially breast cancer (Petrucelli et al., 2010). The gene discussed is BRCA2; the disease is breast carcinoma.